Chinese Journal of Antituberculosis ›› 2018, Vol. 40 ›› Issue (1): 98-105.doi: 10.3969/j.issn.1000-6621.2018.01.022
• Original Articles • Previous Articles Next Articles
Zhi-qi YANG,Yi HU,Qi ZHAO,Yang-gui CHEN,Jian-sheng SUN,Bao-ling RUI,Wei LU,Chang-ming ZHOU,Biao. XU()
Received:
2017-07-07
Online:
2018-01-10
Published:
2018-03-14
Zhi-qi YANG,Yi HU,Qi ZHAO,Yang-gui CHEN,Jian-sheng SUN,Bao-ling RUI,Wei LU,Chang-ming ZHOU,Biao. XU. Treatment outcomes and associated factors among smear-positive pulmonary tuberculosis patients in two counties of Xuzhou, Jiangsu Province and Urumqi, Xinjiang Uygur Autonomous Region[J]. Chinese Journal of Antituberculosis, 2018, 40(1): 98-105. doi: 10.3969/j.issn.1000-6621.2018.01.022
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2018.01.022
特征 | 徐州丰县和沛县(265例) | 乌鲁木齐(309例) | 合计(574例) | χ2值 | P值 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
例数 | 构成比(%) | 例数 | 构成比(%) | 例数 | 构成比(%) | ||||||||||
年龄(岁) | 14.855 | 0.002 | |||||||||||||
<25 | 59 | 22.3 | 59 | 19.1 | 118 | 20.6 | |||||||||
25~ | 66 | 24.9 | 119 | 38.5 | 185 | 32.2 | |||||||||
45~ | 62 | 23.4 | 71 | 23.0 | 133 | 23.2 | |||||||||
65~ | 78 | 29.4 | 60 | 19.4 | 138 | 24.0 | |||||||||
性别 | 10.438 | 0.001 | |||||||||||||
男 | 211 | 79.6 | 209 | 67.6 | 420 | 73.2 | |||||||||
女 | 54 | 20.4 | 100 | 32.4 | 154 | 26.8 | |||||||||
民族 | 145.864 | 0.000 | |||||||||||||
汉族 | 262 | 98.9 | 171 | 55.3 | 433 | 75.4 | |||||||||
少数民族a | 3 | 1.1 | 138 | 44.7 | 141 | 24.6 | |||||||||
特征 | 徐州丰县和沛县(265例) | 乌鲁木齐(309例) | 合计(574例) | χ2值 | P值 | ||||||||||
例数 | 构成比(%) | 例数 | 构成比(%) | 例数 | 构成比(%) | ||||||||||
户籍 | 80.041 | 0.000 | |||||||||||||
本地 | 255 | 96.2 | 205 | 66.3 | 460 | 80.1 | |||||||||
外地 | 10 | 3.8 | 104 | 33.7 | 114 | 19.9 | |||||||||
文化程度 | 5.142 | 0.076 | |||||||||||||
文盲 | 37 | 14.0 | 30 | 9.7 | 67 | 11.7 | |||||||||
小学~高中 | 168 | 63.4 | 187 | 60.5 | 355 | 61.8 | |||||||||
高中以上 | 60 | 22.6 | 92 | 29.8 | 152 | 26.5 | |||||||||
婚姻 | 1.280 | 0.258 | |||||||||||||
已婚 | 185 | 69.8 | 202 | 65.4 | 387 | 67.4 | |||||||||
未婚或离异或丧偶 | 80 | 30.2 | 107 | 34.6 | 187 | 32.6 | |||||||||
务农 | 95.185 | 0.000 | |||||||||||||
是 | 151 | 57.0 | 55 | 17.8 | 206 | 35.9 | |||||||||
否 | 114 | 43.0 | 254 | 82.2 | 368 | 64.1 | |||||||||
家庭收入(元/人年) | 8.657 | 0.003 | |||||||||||||
>2800 | 201 | 77.6 | 262 | 87.0 | 463 | 82.7 | |||||||||
≤2800 | 58 | 22.4 | 39 | 13.0 | 97 | 17.3 | |||||||||
BCG接种 | 30.304 | 0.000 | |||||||||||||
是 | 157 | 59.2 | 112 | 36.2 | 269 | 46.9 | |||||||||
否或不详 | 108 | 40.8 | 197 | 63.8 | 305 | 53.1 | |||||||||
治疗史 | 0.266 | 0.606 | |||||||||||||
初治 | 232 | 87.5 | 266 | 86.1 | 498 | 86.8 | |||||||||
复治 | 33 | 12.5 | 43 | 13.9 | 76 | 13.2 | |||||||||
药敏试验 | 1.761 | 0.642 | |||||||||||||
全敏感 | 219 | 82.6 | 249 | 80.6 | 468 | 81.5 | |||||||||
单耐药 | 29 | 10.9 | 31 | 10.0 | 60 | 10.5 | |||||||||
多耐药 | 6 | 2.3 | 10 | 3.2 | 16 | 2.8 | |||||||||
MDR-TB或XDR-TB | 11 | 4.2 | 19 | 6.1 | 30 | 5.2 | |||||||||
肺部空洞 | 111.713 | 0.000 | |||||||||||||
无 | 55 | 20.8 | 200 | 64.7 | 255 | 44.4 | |||||||||
有 | 210 | 79.2 | 109 | 35.3 | 319 | 55.6 | |||||||||
不良反应 | 4.949 | 0.026 | |||||||||||||
无 | 187 | 70.6 | 243 | 78.6 | 430 | 74.9 | |||||||||
有 | 78 | 29.4 | 66 | 21.4 | 144 | 25.1 | |||||||||
慢性病 | 0.503 | 0.478 | |||||||||||||
无 | 218 | 82.3 | 247 | 79.9 | 465 | 81.0 | |||||||||
有 | 47 | 17.7 | 62 | 20.1 | 109 | 19.0 |
影响因素 | 例数 | 治疗成功(506例) | 不良结局(38例) | χ2值 | P值 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
例数 | 比率(%) | 例数 | 比率(%) | |||||||||
研究现场 | 10.789 | 0.001 | ||||||||||
徐州丰县、沛县 | 254 | 246 | 96.9 | 8 | 3.1 | |||||||
乌鲁木齐 | 290 | 260 | 89.7 | 30 | 10.3 | |||||||
年龄(岁) | 1.395 | 0.707 | ||||||||||
<25 | 111 | 106 | 95.5 | 5 | 4.5 | |||||||
25~ | 176 | 162 | 92.0 | 14 | 8.0 | |||||||
45~ | 126 | 117 | 92.9 | 9 | 7.1 | |||||||
65~ | 131 | 121 | 92.4 | 10 | 7.6 | |||||||
性别 | 4.342 | 0.037 | ||||||||||
男 | 393 | 360 | 91.6 | 33 | 8.4 | |||||||
女 | 151 | 146 | 96.7 | 5 | 3.3 | |||||||
影响因素 | 例数 | 治疗成功(506例) | 不良结局(38例) | χ2值 | P值 | |||||||
例数 | 比率(%) | 例数 | 比率(%) | |||||||||
户籍 | 5.646 | 0.017 | ||||||||||
本地 | 438 | 413 | 94.3 | 25 | 5.7 | |||||||
外地 | 106 | 93 | 87.7 | 13 | 12.3 | |||||||
治疗史 | - | 0.787a | ||||||||||
初治 | 484 | 449 | 92.8 | 35 | 7.2 | |||||||
复治 | 60 | 57 | 95.0 | 3 | 5.0 | |||||||
2个月末痰涂片 | - | 0.000a | ||||||||||
转阴 | 483 | 460 | 95.2 | 23 | 4.8 | |||||||
未转阴 | 61 | 46 | 75.4 | 15 | 24.6 |
变量 | Wald χ2值 | OR值 | 95%CI | P值 |
---|---|---|---|---|
研究现场:乌鲁木齐 | 8.747 | 3.830 | 1.573~9.327 | 0.003 |
年龄:<25岁 | 2.137 | 0.394 | 0.113~1.374 | 0.144 |
年龄:25~岁 | 0.935 | 0.623 | 0.239~1.626 | 0.334 |
年龄:45~岁 | 0.804 | 0.629 | 0.229~1.731 | 0.370 |
性别:女 | 4.710 | 0.329 | 0.121~0.898 | 0.030 |
户籍:外地 | 2.573 | 2.002 | 0.857~4.676 | 0.109 |
治疗史:复治 | 0.561 | 0.615 | 0.173~2.191 | 0.454 |
2个月末痰涂片:未阴转 | 24.679 | 6.892 | 3.218~14.762 | 0.000 |
影响因素 | 徐州丰县和沛县(254例) | 乌鲁木齐(290例) | |||||||
---|---|---|---|---|---|---|---|---|---|
例数 | 治疗成功 [例数 (比率,%)] | 不良结局 [例数 (比率,%)] | P值a | 例数 | 治疗成功 [例数 (比率,%)] | 不良结局 [例数 (比率,%)] | χ2值 | P值 | |
年龄(岁) | 0.189a | 0.415 | 0.937 | ||||||
<25 | 56 | 56(100.0) | 0(0.0) | 55 | 50(90.9) | 5(9.1) | |||
25~ | 62 | 60(96.8) | 2(3.2) | 114 | 102(89.5) | 12(10.5) | |||
45~ | 60 | 59(98.3) | 1(1.7) | 66 | 58(87.9) | 8(12.1) | |||
65~ | 76 | 71(93.4) | 5(6.6) | 55 | 50(90.9) | 5(9.1) | |||
性别 | 0.211a | 4.387 | 0.036 | ||||||
男 | 201 | 193(96.0) | 8(4.0) | 192 | 167(87.0) | 25(13.0) | |||
女 | 53 | 53(100.0) | 0(0.0) | 98 | 93(94.9) | 5(5.1) | |||
户籍 | 0.034a | 0.192 | 0.661 | ||||||
本地 | 244 | 238(97.5) | 6(2.5) | 194 | 175(90.2) | 19(9.8) | |||
外地 | 10 | 8(80.0) | 2(20.0) | 96 | 85(88.5) | 11(11.5) | |||
治疗史 | 0.180a | - | 0.147a | ||||||
初治 | 229 | 223(97.4) | 6(2.6) | 255 | 226(88.6) | 29(11.4) | |||
复治 | 25 | 23(92.0) | 2(8.0) | 35 | 34(97.1) | 1(2.9) | |||
2个月末痰涂片 | 0.006a | - | 0.000a | ||||||
转阴 | 226 | 222(98.2) | 4(1.8) | 257 | 238(92.6) | 19(7.4) | |||
未转阴 | 28 | 24(85.7) | 4(14.3) | 33 | 22(66.7) | 11(33.3) |
变量 | 徐州丰县和沛县 | 乌鲁木齐 | ||||||
---|---|---|---|---|---|---|---|---|
Wald χ2值 | OR值 | 95%CI | P值 | Wald χ2值 | OR值 | 95%CI | P值 | |
年龄:<25岁 | 0.000 | 0.000 | 0.000~0.000 | 0.997 | 0.115 | 0.781 | 0.187~3.257 | 0.734 |
年龄:25~岁 | 2.039 | 0.097 | 0.004~2.381 | 0.153 | 0.000 | 1.003 | 0.303~3.321 | 0.996 |
年龄:45~岁 | 1.864 | 0.185 | 0.016~2.084 | 0.172 | 0.069 | 1.184 | 0.336~4.169 | 0.792 |
性别:女 | 0.000 | 0.000 | 0.000~0.000 | 0.997 | 2.798 | 0.414 | 0.148~1.163 | 0.094 |
户籍:外地 | 5.907 | 57.937 | 2.194~1529.769 | 0.015 | 0.343 | 1.304 | 0.537~3.164 | 0.558 |
治疗史:复治 | 0.171 | 1.481 | 0.230~9.529 | 0.679 | 2.225 | 0.203 | 0.025~1.651 | 0.136 |
2个月末痰涂片:未阴转 | 7.316 | 9.460 | 1.857~48.199 | 0.007 | 15.791 | 6.083 | 2.497~14.819 | 0.000 |
[1] | World Health Organization . Global tuberculosis report 2017. Geneva:World Health Organization, 2017. |
[2] | 全国第五次结核病流行病学抽样调查技术指导组, 全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告. 中国防痨杂志, 2012,34(8):485-508. |
[3] |
Huang Q, Yin Y, Kuai S , et al. The value of initial cavitation to predict re-treatment with pulmonary tuberculosis. Eur J Med Res, 2016,21(1):20.
doi: 10.1186/s40001-016-0214-0 URL |
[4] | 韩志英, 顾凯侃, 朱小珍 , 等. 上海市静安区1999—2008年肺结核患者转归状况调查. 中国预防医学杂志, 2010,11(8):785-788. |
[5] | 陈红光, 王春霞, 刘海涛 , 等. 757例初治肺结核患者抗结核治疗效果影响因素分析. 中国防痨杂志, 2013,35(5):357-360. |
[6] | World Health Organization . Global tuberculosis report 2016. Geneva:World Health Organization, 2016. |
[7] |
Li X, Yang Y, Liu J , et al. Treatment outcomes of pulmonary tuberculosis in the past decade in the mainland of China: a meta-analysis. Front Med, 2013,7(3):354-366.
doi: 10.1007/s11684-013-0257-3 URL |
[8] |
吕静 . 武汉市硚口区登记肺结核病流行特征及治疗结局分析. 武汉:华中科技大学, 2011.
doi: 10.7666/d.d189631 URL |
[9] |
Thorson A, Diwan VK . Gender inequalities in tuberculosis: aspects of infection, notification rates, and compliance. Curr Opin Pulm Med, 2001,7(3):165-169.
doi: 10.1097/00063198-200105000-00009 URL pmid: 11371773 |
[10] |
Shen X, Xia Z, Li X , et al. Tuberculosis in an urban area in China: differences between urban migrants and local residents. PLoS One, 2012,7(11):e51133.
doi: 10.1371/journal.pone.0051133 URL pmid: 3511410 |
[11] |
Chen J, Qi L, Xia Z , et al. Which urban migrants default from tuberculosis treatment in Shanghai, China? PLoS One, 2013,8(11):e81351.
doi: 10.1371/journal.pone.0081351 URL pmid: 3842957 |
[12] |
Wei X, Chen J, Chen P , et al. Barriers to TB care for rural-to-urban migrant TB patients in Shanghai: a qualitative study. Trop Med Int Health, 2009,14(7):754-760.
doi: 10.1111/j.1365-3156.2009.02286.x URL pmid: 19392747 |
[13] |
Garcia-Garcia JM, Blanquer R, Rodrigo T , et al. Social, clinical and microbiological differential characteristics of tuberculosis among immigrants in Spain. PLoS One, 2011,6(1):e16272.
doi: 10.1371/journal.pone.0016272 URL |
[14] |
Wang W, Wang J, Zhao Q , et al. Contribution of rural-to-urban migration in the prevalence of drug resistant tuberculosis in China. Eur J Clin Microbiol Infect Dis, 2011,30(4):581-586.
doi: 10.1007/s10096-010-1125-6 URL |
[15] | World Health Organization . Treatment of tuberculosis guidelines, fourth edition. Geneva:World Health Organization, 2010. |
[16] |
Djouma FN, Noubom M, Ateudjieu J , et al. Delay in sputum smear conversion and outcomes of smear-positive tuberculosis patients: a retrospective cohort study in Bafoussam, Cameroon. BMC Infect Dis, 2015,15:139.
doi: 10.1186/s12879-015-0876-1 URL |
[17] |
Ukwaja KN, Oshi DC, Oshi SN , et al. Profile and treatment outcome of smear-positive TB patients who failed to smear convert after 2 months of treatment in Nigeria. Trans R Soc Trop Med Hyg, 2014,108(7):431-438.
doi: 10.1093/trstmh/tru070 URL |
[18] | Tiwari S, Kumar A, Kapoor SK . Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots—a prospective cohort study. Indian J Tuberc, 2012,59(3):135-140. |
[19] |
Nakaggwa P, Odeke R, Kirenga BJ , et al. Incomplete sputum smear microscopy monitoring among smear-positive tuberculosis patients in Uganda. Int J Tuberc Lung Dis, 2016,20(5):594-599.
doi: 10.5588/ijtld.15.0591 URL |
[20] |
Satyanarayana S, Nagaraja SB, Kelamane S , et al. Did successfully treated pulmonary tuberculosis patients undergo all follow-up sputum smear examinations Public Health Action, 2011,1(2):27-29.
doi: 10.5588/pha.11.0013 URL |
[21] |
Kayigamba FR, Bakker MI, Mugisha V , et al. Adherence to tuberculosis treatment, sputum smear conversion and mortality: a retrospective cohort study in 48 Rwandan clinics. PLoS One, 2013,8(9):e73501.
doi: 10.1371/journal.pone.0073501 URL |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||